Performance Evaluation of the i-SmartCare 10 Analyzer and Method Comparison of Six Point-of-Care Blood Gas Analyzers
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Blood gas, electrolyte, glucose, and lactate level measurement have an immediate and critical impact on patient care. We evaluated the performance of i-SmartCare 10 (i-SENS Inc., Seoul, Korea) and conducted a method comparison study of five point-of-care (POC) analyzers with i-SmartCare 10 as the comparator, according to the CLSI guidelines. Ten analytes (pH, pCO2, pO2, Na+, K+, Cl−, iCa2+, glucose, lactate, and Hct) were tested on six analyzers: i-SmartCare 10, ABL90 FLEX PLUS (Radiometer Medical ApS, Copenhagen, Denmark), i-Stat (Abbott Point of Care Inc., Princeton, NJ, USA), RapidLab 1265 (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA), Stat Profile pHOx Ultra (Nova Biomedical, Waltham, MA, USA), and Gem Premier 5000 (Instrumentation Laboratory, Bedford, MA, USA). The total imprecision and linearity (r2>0.99) were excellent, except for a few analytes that narrowly escaped the preset criteria. Interference was noted for Na+ in the presence of a high K+ level and for iCa2+ in the presence of high K+ and Mg2+ levels. Forty of 48 items demonstrated either a proportional or systematic difference in regression analysis; the relative mean difference (%) of 14/48 items escaped the allowable total error in the difference plot analysis. i-SmartCare 10 shows acceptable performance, and using a single POC blood gas analyzer is recommended for monitoring.
Abstract
Blood gas, electrolyte, glucose, and lactate level measurement have an immediate and critical impact on patient care. We evaluated the performance of i-SmartCare 10 (i-SENS Inc., Seoul, Korea) and conducted a method comparison study of five point-of-care (POC) analyzers with i-SmartCare 10 as the comparator, according to the CLSI guidelines. Ten analytes (pH, pCO2, pO2, Na+, K+, Cl−, iCa2+, glucose, lactate, and Hct) were tested on six analyzers: i-SmartCare 10, ABL90 FLEX PLUS (Radiometer Medical ApS, Copenhagen, Denmark), i-Stat (Abbott Point of Care Inc., Princeton, NJ, USA), RapidLab 1265 (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA), Stat Profile pHOx Ultra (Nova Biomedical, Waltham, MA, USA), and Gem Premier 5000 (Instrumentation Laboratory, Bedford, MA, USA). The total imprecision and linearity (r2>0.99) were excellent, except for a few analytes that narrowly escaped the preset criteria. Interference was noted for Na+ in the presence of a high K+ level and for iCa2+ in the presence of high K+ and Mg2+ levels. Forty of 48 items demonstrated either a proportional or systematic difference in regression analysis; the relative mean difference (%) of 14/48 items escaped the allowable total error in the difference plot analysis. i-SmartCare 10 shows acceptable performance, and using a single POC blood gas analyzer is recommended for monitoring.
참고문헌 (20)
- Fermann GJ, "Point of care testing in the emergency department", J Emerg Med, 22, pp.393~404 (2002)
- Price CP, "Point of care testing", BMJ, 322, pp.1285~1288 (2001)
- van Heyningen C, "Point-of-care testing outcomes in an emergency department", Clin Chem, 45, pp.437~438 (1999)
- Cas Weykamp, "HbA1c: A Review of Analytical and Clinical Aspects", Annals of Laboratory Medicine, 33(6), pp.393~400 (2013), 대한진단검사의학회
- De Koninck AS, "Analytical performance evaluation of four cartridge-type blood gas analyzers", Clin Chem Lab Med, 50, pp.1083~1091 (2012)
- Uyanik M, "Comparison of blood gas, electrolyte and metabolite results measured with two different blood gas analyzers and a core laboratory analyzer", Scand J Clin Lab Invest, 75, pp.97~105 (2015)
- Leino A, "Interchangeability of blood gas, electrolyte and metabolite results measured with point-of-care, blood gas and core laboratory analyzers", Clin Chem Lab Med, 49, pp.1187~1191 (2011)
- Indrasari ND, "Comparison of point-of-care and central laboratory analyzers for blood gas and lactate measurements", J Clin Lab Anal, 33, pp.e22885~ (2019)
- Oliver P, "Analytical performance evaluation and comparability of patient results within a point-of-care blood gas network", Point of Care, 12, pp.144~149 (2013)
- Stadlbauer V, "Comparison of 3 different multianalyte point-of-care devices during clinical routine on a medical intensive care unit", J Crit Care, 26, pp.433~ (2011)
- CLSI, "Evaluation of precision of quantitative measurement procedures; approved guideline" (2014), Clinical and Laboratory Standards Institute
- CLSI, "Evaluation of the linearity of quantitative measurement procedures: A statistical approach; approved guideline" (2003), Clinical and Laboratory Standards Institute
- CLSI, "Interference testing in clinical chemistry; approved guideline" (2005), Clinical and Laboratory Standards Institute
- CLSI, "Supplemental tables for interference testing in clinical chemistry" (2018), Clinical and Laboratory Standards Institute
- CLSI, "Measurement procedure comparison and bias estimation using patient samples; approved guideline" (2013), Clinical and Laboratory Standards Institute
- Ricós C, "Current databases on biological variation: Pros, cons and progress", Scand J Clin Lab Invest, 59, pp.491~500 (1999)
- "Biological variation database, and quality specifications for imprecision, bias and total error" (2014)[URL]
- Jhang JS, "Evaluation of linearity in the clinical laboratory", Arch Pathol Lab Med, 128, pp.44~48 (2004)
- "Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)-HCFA. Final rule with comment period", Fed Regist 1992;57:7002-186, ~ (1992)
- Ariadna Arbiol-Roca, "Stability of pH, Blood Gas Partial Pressure, Hemoglobin Oxygen Saturation Fraction, and Lactate Concentration", Annals of Laboratory Medicine, 40(6), pp.448~456 (2020), 대한진단검사의학회[DOI]
